Time: Every Thursday at 12:20pm - 1:20pm

Cancer Research Building 2, 1550 Orleans St, 1M.13
Baltimore, MD

Background Treatment success rates for multidrug-resistant tuberculosis (MDR-TB) in South Africa remain close to 50%. Lack of...

Objectives. We sought to characterize postimmigration tuberculosis (TB) care for Class B immigrants and refugees at the...

Nearly 20 years after the World Health Organization declared tuberculosis (TB) a global public health emergency, TB...

Aim: There is controversy regarding the potential fitness costs of rifampicin (RIF) resistance-conferring mutations in...

Tuberculosis (TB) has recently surpassed HIV as the primary infectious disease killer worldwide, but the two...